Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions

End-stage renal disease patients require peritoneal dialysis (PD) as a life-saving therapy; however, they continue to experience systemic inflammation and increased cardiovascular pathology. These complications can be exacerbated by exposure to PD solutions (PDS) containing glucose. This highlights...

Celý popis

Podrobná bibliografia

Vydané v:	Nephrology, dialysis, transplantation
Hlavní autori:	Kopytina, Valeria, Marchant, Vanessa, Rodrigues-Diez, Raquel, Pascual-Antón, Lucía, Toggweiler, Nora, Strahl, Lisa, Kane, Jamie, Tejera-Muñoz, Antonio, Cortés, Marcelino, Sucunza, David, Vaquero, Juan J, Vervloet, Marc, Piecha, Dorothea, Eringa, Etto C, Ruiz-Ortega, Marta, López-Cabrera, Manuel, González-Mateo, Guadalupe T
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 13.11.2025
Predmet:	cardiovascular disease peritoneal dialysis osmotic agent biocompatibility kidney replacement therapy
ISSN:	1460-2385, 1460-2385
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!